• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III.

作者信息

Favaloro Emmanuel J, Lippi Giuseppe

机构信息

Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia.

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

出版信息

Semin Thromb Hemost. 2022 Feb;48(1):3-7. doi: 10.1055/s-0041-1736169. Epub 2022 Feb 1.

DOI:10.1055/s-0041-1736169
PMID:35104908
Abstract
摘要

相似文献

1
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III.2019冠状病毒病（COVID-19）中的止血维持与血栓形成预防 - 第三部分
Semin Thromb Hemost. 2022 Feb;48(1):3-7. doi: 10.1055/s-0041-1736169. Epub 2022 Feb 1.
2
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I.2019冠状病毒病（COVID-19）中的止血维持与血栓形成预防——第一部分
Semin Thromb Hemost. 2020 Oct;46(7):757-762. doi: 10.1055/s-0040-1717139. Epub 2020 Oct 20.
3
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.2019冠状病毒病（COVID-19）中的止血维持与血栓形成预防：第二部分。
Semin Thromb Hemost. 2021 Jun;47(4):333-337. doi: 10.1055/s-0041-1728775. Epub 2021 Jun 1.
4
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part IV.
Semin Thromb Hemost. 2023 Feb;49(1):3-8. doi: 10.1055/s-0042-1759736. Epub 2023 Jan 5.
5
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?].[新型冠状病毒肺炎相关血栓形成风险的管理：止血实验室的作用是什么？]
Ann Biol Clin (Paris). 2020 Oct 1;78(5):471-481. doi: 10.1684/abc.2020.1581.
6
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study.重症 COVID-19 患者的动态止血和纤溶检测及其与血栓形成和出血的相关性：系统评价和队列研究。
Semin Thromb Hemost. 2022 Feb;48(1):31-54. doi: 10.1055/s-0041-1735454. Epub 2021 Oct 29.
7
Productivity of Young Experts in Hemostasis and Thrombosis before and during the SARS-CoV-2 Pandemic-A Special Issue.SARS-CoV-2大流行之前及期间止血与血栓形成领域青年专家的生产力——特刊
Hamostaseologie. 2020 Aug;40(3):255-256. doi: 10.1055/a-1081-6973. Epub 2020 Jul 29.
8
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
9
Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.乙酰水杨酸（阿司匹林）：一种预防由血栓形成和肺栓塞导致的新冠死亡的有效药物。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9244-9245. doi: 10.26355/eurrev_202009_23005.
10
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.高剂量依诺肝素用于COVID-19患者的血栓预防真的有必要吗？一项新的“审慎”随机临床试验。
Blood Transfus. 2020 May;18(3):237-238. doi: 10.2450/2020.0109-20.

引用本文的文献

1
Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection.COVID-19 感染期间先天性血栓形成患者的血栓形成风险评估。
Thromb Res. 2022 Oct;218:151-156. doi: 10.1016/j.thromres.2022.08.020. Epub 2022 Aug 20.
2
Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes.新冠肺炎患者入住重症监护病房后持久的功能受限，以及中剂量与标准剂量抗凝治疗对功能结局的影响。
Eur J Intern Med. 2022 Sep;103:76-83. doi: 10.1016/j.ejim.2022.06.014. Epub 2022 Jun 20.